Search by Journal
- HOME
- > Search by Journal
- > Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences
Volume , Issue suppl.1 / 2016
English Article 
Japanese Article- Please note that metadata of J-type articlesare generated by machine-translation and the original texts are written in Japanese.
|
Team approach in medical care annual convention long greetings to make tomorrow in the 26th Japan cure society annual convention holding 松原和夫 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 3-3, 2016. |
|---|
|
|
Team approach in medical care to make tomorrow 松原和夫 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 172-172, 2016. |
|---|
|
|
The present conditions and problem of the PD-1 checkpoint inhibition cancer immune therapy 湊長博 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 172-172, 2016. |
|---|
|
Precision Medicine and Cardiovascular Therapeutics : An Individualized Approach Towards Optimizing Drug Selection and Use Robert J.Straka Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 173-173, 2016. |
|---|
|
|
The Impact of Clinical Pharmacy Services on Cancer Care Richard Tizon Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 173-173, 2016. |
|---|
|
|
We design a study in response to an on-site question 福原俊一 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 174-174, 2016. |
|---|
|
|
Let's shine life Japanese medical medicine society - Team medical center is pharmacist - 邉見公雄 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 174-174, 2016. |
|---|
|
|
To develop new pharmacist work - Let's think about legal interpretation - 赤羽根秀宜 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 175-175, 2016. |
|---|
|
|
Clinical pharmacy study on proper use of the anticancer agent and medical therapy improvement 有森和彦 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 175-175, 2016. |
|---|
|
|
Development of the individualization therapy of the immunosuppressive drug in renal-transplant recipients 加賀谷英彰 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 176-176, 2016. |
|---|
|
|
Study on clinical pharmacy that assumed - inventory survey technique a base for establishment of the fur Matthew tical care to lead to the quality of life improvement of the patients and clinic - 舘知也 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 176-176, 2016. |
|---|
|
|
Study on effectiveness, side effect predictor of the molecular target drug for nephrocyte cancer 山本和宏 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 177-177, 2016. |
|---|
|
|
A pharmacokinetic change of Teiko plastic Nin in the patients with hyperglycemia and the hypoalbuminemia: Effect of the glycosylation of albumin to give albumin combination of Teiko plastic Nin 榎屋友幸 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 177-177, 2016. |
|---|
|
|
Study of the human pharmacology on effectiveness of aminophylline in treatment, the prevention of the premature baby apnea and safety 近藤智子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 178-178, 2016. |
|---|
|
|
Evaluation of a side effect, the effectiveness based on the blood sunitinib levels monitoring in patients with nephrocyte cancer 野田哲史 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 178-178, 2016. |
|---|
|
|
The metabolism saturation of becoming it causes non-linear pharmacokinetics of voriconazole in the clinical dose N oxide of voriconazole 山田尚広 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 179-179, 2016. |
|---|
|
|
Study on prevention, therapeutic drug of stomatitis to occur at cancer chemotherapy / radiotherapy 渡邉真一 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 179-179, 2016. |
|---|
|
|
We examine 1 disease and are promoted the team approach in medical care in the area by the medicine cooperation 今井博久, 矢野育子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 182-182, 2016. |
|---|
|
|
We talk about tomorrow of 2 hospital pharmacist 松原和夫 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 182-182, 2016. |
|---|
|
|
We regard innovative drug development as the new medical care using 3 iPS cells 中川貴之 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 182-182, 2016. |
|---|
|
|
Disaster medical care support report in the Kumamoto earthquake 渡邉暁洋, 眞野成康 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 183-183, 2016. |
|---|
|
|
New and prospective profession of pharmacists in medical team Yasuo Takeda, Takao Orii Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 183-183, 2016. |
|---|
|
|
Display ... of the professional ability in side effect management "- team approach in medical care of" cancer medical therapy that only 1 pharmacist has 松尾宏一, 野村久祥 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 184-184, 2016. |
|---|
|
|
Approach of the prior learning that fixed its eyes on 2 revision core Cali 野田幸裕, 木津純子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 184-184, 2016. |
|---|
|
|
Construction and development ... of many types of job cooperation ... new pharmacist duties to utilize genome information for 3 pharmacist duties 平井みどり, 山本和宏 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 184-184, 2016. |
|---|
|
|
Personnel training of the next-generation pharmacist who can take four teams medical care 松尾宏一, 吉村知哲 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 184-184, 2016. |
|---|
|
|
Role of the pharmacist in the treatment of patients with advanced age diabetes to support in five teams 三宅健文, 三浦彰久 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 185-185, 2016. |
|---|
|
|
How do you connect the clinical question of 6 pharmacists with a research question? 内藤隆文, 新岡丈典 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 185-185, 2016. |
|---|
|
|
What a pharmacist should do by the team approach in medical care of 7 children domains, the significance of existence 冨家俊弥, 小高賢一 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 185-185, 2016. |
|---|
|
|
The present conditions and problem of the in-hospital governance of 8 high risk medicine management 三宅健文, 渡邉幸子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 185-185, 2016. |
|---|
|
|
It is ... starting from the clinical analysis of 9 pharmaceutical products safe sexological advice - pharmaceutical products adverse effect 宇野勝次, 佐藤光利 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 186-186, 2016. |
|---|
|
|
It is consideration to ... future and fine-view ... about the cooperation between an activity and pharmacists of the each team approach in medical care by 10 many types of job cooperation 西原雅美, 八木達也 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 186-186, 2016. |
|---|
|
|
New development of the team approach in medical care that a pharmacist challenges in 11 next generation 小林政彦, 尾上雅英 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 186-186, 2016. |
|---|
|
|
With the role that a pharmacist should fulfil in team approach in medical care to support 12 cardiovascular disease case? 野崎歩, 芦川直也 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 186-186, 2016. |
|---|
|
|
An art and theory to evaluate 13 renal function definitely 平田純生, 小林道也 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 187-187, 2016. |
|---|
|
|
Role ... which a pharmacist achieves for the cooperation to cooperation duties - health insurance pharmacy, the hospital transfer institution which started from 14 ward exclusive duty pharmacists 三上正, 橋田亨 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 187-187, 2016. |
|---|
|
|
Ad usum externum therapy for pressure sore that 15 pharmacists practice 宮地良樹, 関根祐介 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 187-187, 2016. |
|---|
|
|
We regard a tool as knowledge necessary for a pharmacist confronting 16 resistant bacteria measures! - How do you make use of Japan Antimicrobial Consumption Surveillance (the JACS)? - 北原隆志, 村木優一 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 187-187, 2016. |
|---|
|
|
17 Is disease cooperation really useful? - Effects of inhalation support collaboration and what has been visible from it - 篠永浩, 百瀬泰行 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 188-188, 2016. |
|---|
|
|
One or ... that inspiration - pharmacist for 18 pharmacists to survive the smart platinum era is concerned with information cooperation how 小枝伸行 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 188-188, 2016. |
|---|
|
|
... which let's promote the work life management of 19 pharmacists, and thinks about coexistence support in ... Japan and Europe rice, reinstatement support and various ways of working 岩澤真紀子, 上塚朋子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 188-188, 2016. |
|---|
|
|
... which thinks about technique to perform religious austerities in winter of theory and practice ... enlarging drug duties of 20 drugstore management premeditatedly 赤瀬朋秀, 加賀谷肇 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 188-188, 2016. |
|---|
|
|
... which thinks about perioperative safety management and practice of the patients care to take by 21 perioperative care teams and operating room drug duties - team which a pharmacist receives 舟越亮寛, 落合亮一 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 189-189, 2016. |
|---|
|
|
The mission of the pharmacist who showed 22, and should carry it out by cancer palliative care and way to advance to 高橋一栄, 祝千佳子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 189-189, 2016. |
|---|
|
|
How is pharmacoepidemiology - safety of medicine not to be able to hear 23 now evaluated? A study in the practical medical care and institutional problem 漆原尚巳, 中川俊作 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 189-189, 2016. |
|---|
|
|
Role ... of the academia for practice - team approach in medical care promotion of clinical studies by the cooperation with 24 pharmacy schools and hospital, drugstore 辻大樹, 林秀樹 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 189-189, 2016. |
|---|
|
|
Practice ... of quantitative approach - clinical Pharmacometrics to make 25 medical treatment adequate individually 西村信弘, 猪川和朗 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 190-190, 2016. |
|---|
|
|
... which thinks about a student evaluation in ... business training for pharmacist upbringing in response to needs of 26 society 千堂年昭, 寺町ひとみ Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 190-190, 2016. |
|---|
|
|
The safe system, safety measures to affect use of 27 pharmaceutical products: With hospital governance reform and the decision-making figure which there should be? 川上純一, 堀雄史 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 190-190, 2016. |
|---|
|
|
28 Let's learn from past cases and think about disaster medical system - Spread information from a pharmacist - 渡邉暁洋, 西澤健司 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 190-190, 2016. |
|---|
|
|
Improvement of the medical treatment effect by 29 pre-Abo id new stage (the world of style 3) formulation study, suggestion 笠原英城, 舟越亮寛 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 191-191, 2016. |
|---|
|
|
Way of thinking - of one or the side effect using - pharmaceutical clinical reasoning to reason in 30 adverse events and causation of pharmaceutical products how 川口崇, 岸田直樹 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 191-191, 2016. |
|---|
|
|
How does the pharmacist utilize safe medical therapy guidelines on issue of polypharmacy - elderly people 2015 to surround 31 elderly people medical therapy? - 溝神文博, 平井みどり Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 191-191, 2016. |
|---|
|
|
... which regards the gap of the healthcare setting as contraindicated - regulation of 32 pharmaceutical products 佐藤博, 寺田智祐 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 191-191, 2016. |
|---|
|
|
Many types of job cooperation education (IPE) which supports 33 teams medical care: We will spread IPE! 野田幸裕, 杉山正 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 192-192, 2016. |
|---|
|
|
Anything is necessary so that 34 pharmacists do prospective clinical studies; or is ... from the making of system beyond ... type of job to a design, an ethic 山口拓洋, 東加奈子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 192-192, 2016. |
|---|
|
|
To show a role and the usefulness of promotion - pharmacist of clinical studies in 35 community pharmacy; - 荒井國三, 赤沢学 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 192-192, 2016. |
|---|
|
|
Peripheral neuropathy with 36 anticancer agents: The actions to be taken and recent study trend 石田竜弘, 岩本卓也 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 192-192, 2016. |
|---|
|
|
Proper use of 37 transdermal absorbing form preparation and future development 北河修治, 大谷道輝 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 193-193, 2016. |
|---|
|
|
Summary of a fact and the case summary of the pharmaceutical intervention in 38 cancer medical therapy 濱敏弘, 谷川原祐介 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 193-193, 2016. |
|---|
|
|
Relation of the pharmacist in 39 Nuclear medicine domains 土屋文人, 間賀田泰寛 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 193-193, 2016. |
|---|
|
|
The Pharmacometrics which contributes to the solution to 40 clinical on-site questions, problems 永田将司, 本間雅 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 193-193, 2016. |
|---|
|
|
One or - that - pharmacist thinking about medical therapy is associated with 41 mother's milk child care how 石川洋一, 植松和子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 194-194, 2016. |
|---|
|
|
We think about 42 drug-related renal failure 竹内裕紀, 古久保拓 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 194-194, 2016. |
|---|
|
|
43 We think about the future of dementia treatment - what pharmacists can and shold do the future - 伊東弘樹, 永冨将寛 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 194-194, 2016. |
|---|
|
|
The present and the future of 44 "family pharmacists, drugstores" 宮崎長一郎, 吉山友二 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 194-194, 2016. |
|---|
|
|
How should the pharmacist be concerned with the proper use of 45 antifungal agents? 新岡丈典, 西村信弘 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 195-195, 2016. |
|---|
|
|
Polypharmacy ... to regard as problems over 46 polypharmacy by landing point ... many types of job 武藤浩司, 増田修三 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 195-195, 2016. |
|---|
|
|
Long-term medication management ... which is carried out by HIV infection - team as 47 chronic diseases 尾崎淳子, 矢倉裕輝 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 195-195, 2016. |
|---|
|
|
Construction of the safe measures for the LS1-1 / LS1-2 immunity checkpoint inhibitor 永井宏樹, 清水克次 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 205-205, 2016. |
|---|
|
|
Suggestion - of the illness cancer pain treatment in LS2 outpatient department cancer treatment that we examined it and matched with medicine cooperation - lifestyle 鹿田康紀, 池田宗彦 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 205-205, 2016. |
|---|
|
|
Is the LS3 SGLT2 inhibitor same as sugar restrictions? 福井道明 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 206-206, 2016. |
|---|
|
|
It is some ... with the role of LS4 elderly people medical therapy and Polypharmacy measures - pharmacist 竹屋泰 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 206-206, 2016. |
|---|
|
|
... including an example, the attention awakening of the proper use ... amount of Mg blood symptom of the laxative for patients with LS5 elderly people, kidney disease 平田純生 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 207-207, 2016. |
|---|
|
|
Mainly on strategic - cancer medical care of five to show an LS6 pharmacist power - 吉村知哲 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 207-207, 2016. |
|---|
|
|
It is ... including proper use and the evaluation of directional - plasma derivative of LS7 health care overhaul and the hospital pharmacist evaluation 谷澤正明 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 208-208, 2016. |
|---|
|
|
Anticancer medicine exposure measures judging from LS8 United States Pharmacopeia of Japan 濱宏仁 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 208-208, 2016. |
|---|
|
|
LS9 Handling standards for sterile preparations and hazardous drags: Learn about the US Pharmacopoeia (USP) <797> and <800> - Talking in the position of the US Pharmacopoeia (USP) - Ryan A.Forrey Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 209-209, 2016. |
|---|
|
|
Collective strength of the pharmacist coordinating LS10 team approach in medical care 山本克己 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 209-209, 2016. |
|---|
|
|
Is the LS11 SGLT2 inhibitor higher-risk than DPP-4 inhibitor? 栄田敏之 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 210-210, 2016. |
|---|
|
|
Experience the pharmacist training specialized in cancer in - other institutions about a pharmacist training institution specialized in LS12-1 cancer; and - 大辻貴司 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 210-210, 2016. |
|---|
|
|
As a viewpoint to accept a pharmacist intern specialized in a cancer from - other institutions about a pharmacist training institution specialized in LS12-2 cancer - 濱敏弘 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 210-210, 2016. |
|---|
|
|
LS13 Mechanisms and Management of drug-drug interactions with Direct Acting Antivirals in Hepatitis C treatment David Back Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 211-211, 2016. |
|---|
|
|
Next-generation preparation - for latent energy - medication characteristics improvement of the LS14 pharmacist 倉田なおみ Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 211-211, 2016. |
|---|
|
|
LS15 drugstore pre-Abo id and medicine medicine cooperation 澤田康文 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 212-212, 2016. |
|---|
|
|
Making of medical therapy support - various calculation, conversion tools that we utilized LS16 inside the hospital intranet and operational - 篠道弘 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 212-212, 2016. |
|---|
|
|
Thing - that it seemed that role - surgeon of a drugstore, the pharmacist in the LS17 area inclusion care system returned to the drugstore 狭間研至 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 213-213, 2016. |
|---|
|
|
LS18 pharmacist-related policy trend and use promotion of the generic drug 川上純一 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 213-213, 2016. |
|---|
|
|
LS19 Colon cancer chemotherapy to make team medicine successful - What pharmacists can do with doctors - 石橋敬一郎, 佐野元彦 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 214-214, 2016. |
|---|
|
|
With the cost effectiveness evaluation of the LS20 medicine? Situation of ... foreign countries and domestic future ... 五十嵐中 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 214-214, 2016. |
|---|
|
|
You aim at the prescription of treatment with Chinese medicine - physician carried out by the LS21 many types of job, and are you found? ... 間宮敬子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 215-215, 2016. |
|---|
|
|
LS22 locomotive syndrome and osteoarthritis 星野雄一 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 215-215, 2016. |
|---|
|
|
After LS23 stomach cancer, an operation in colon cancer about adjuvant chemotherapy and the management 山口研成 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 216-216, 2016. |
|---|
|
|
Invention ... for point - adherence improvement of LS24 life-style related diseases treatment that we want to suppress 桝田出 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 216-216, 2016. |
|---|
|
|
It is ... from adequacy of the LS25 medical therapy and role - instruction of the pharmacist to behavior 中村敏明 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 217-217, 2016. |
|---|
|
|
ADPKD practice from LS26 this 瀬田公一 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 217-217, 2016. |
|---|
|
|
In the LS27 new antiepileptic drug, the TDM is necessary! - Message - from a clinician to a pharmacist 岩崎俊之 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 218-218, 2016. |
|---|
|
|
cost and value of LS28 lung cancer treatment 國頭英夫 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 218-218, 2016. |
|---|
